Warm lung transport device aims to cut transplant failure
NCT ID NCT07340710
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device that keeps donor lungs warm and breathing during transport, instead of putting them on ice. The goal is to reduce severe lung swelling (edema) after transplant, which can lead to failure. About 450 lung transplant patients will take part, with two-thirds getting the device and one-third getting standard cold storage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- OCS Lung System (a device that keeps donor lungs warm and breathing during transport)
- What this could lead to
- If successful, this device could reduce early lung failure after transplant, helping more patients recover without severe complications.
- What could go wrong
- This trial hasn't started yet, and the device is compared to standard cold storage. It may not show a clear benefit, and device-related risks are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fewer heart scans during lung transplant may ease swallowing after surgery
- Could a simple neck band protect transplanted lungs from stomach acid?
- Lung transplant showdown: which surgical method wins?
- New registry aims to boost lung transplants by reconditioning donor lungs
- New drug trial aims to rescue failing lungs after transplant
- New hope for lung transplant patients: drug may block dangerous virus